Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use PARICALCITOL INJECTION safely and effectively. See full prescribing information for PARICALCITOL INJECTION. PARICALCITOL INJECTION, for intravenous use Initial U.S. Approval: 1998
Medication labelWhy this: Advisory · dailymed-prescription
Paricalcitol Injection is an active vitamin D2 analogue indicated for the prevention and treatment of secondary hyperparathyroidism associated with chronic kidney disease (CKD) Stage 5.
- generic_name
- paricalcitol
- product_names
- Paricalcitol
- ndc
- 0143-9625, 0143-9624, 0143-9596, 0143-9625-01, 0143-9625-25, 0143-9624-01, 0143-9624-25, 0143-9596-01, 0143-9596-25
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en